NCT05077150View on ClinicalTrials.gov

A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCT

CompletedOBSERVATIONAL
Enrollment

168

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Pneumocystis Pneumonia
Trial Locations (9)

1097

United St. Istvan and St. Laszlo Hospital, Budapest

3000

University Hospital Gasthuisberg, Leuven

20251

University Hospital Eppendorf, Hamburg

31096

Rambam Medical Center, Haifa

75475

Hopital St. Louis, Paris

80054

University of Amiens: CHU Amiens, Amiens

94010

Hôpital Henri Mondor, Créteil

F-59037

Hôpital Huriez, Lille

PB 4950

Oslo University Hospital, Rikshospitalet, Oslo

All Listed Sponsors
lead

European Society for Blood and Marrow Transplantation

NETWORK

NCT05077150 - A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCT | Biotech Hunter | Biotech Hunter